Slezin eye drops solution 0.5% 10ml №1

Name:
Tears.
Description:
An opalescent solution without visible particles. The main active ingredient is hypromellose. Release form Drops. Dosage 10 ml. Pharmacological action Other agents used in ophthalmology. Artificial tear and other indifferent means. ATX CODE S01XA20. Pharmacokinetics Hypromellose refers to inert substances, it does not have pharmacological activity. Indications for use Topically used to relieve symptoms of dry eye syndrome and eye irritation associated with inadequate tear production (eg, in patients with rheumatoid arthritis, keratoconjunctivitis sicca, and xerophthalmia). Dosage and administration The drug is intended for topical use only. Unless otherwise prescribed by a doctor, apply one to two drops into the conjunctival sac of the eye(s) three times a day. The dosage regimen and the duration of the use of the drug are determined by the doctor, taking into account the characteristics of the disease, the effect achieved and the tolerability of the drug. Instructions for use of eye drops Wash your hands before use. Open the vial. Turn the vial upside down, holding the vial between your thumb and forefinger. Tilt your head back. Pull the lower eyelid down slightly to form a “pocket” between the eyelid and the eye, into which the drop should fall. Hold the vial upside down over the eye and gently squeeze the vial to squeeze the drop into the eye. Do not squeeze the vial too hard. Do not touch the dropper tip to any surface (eyelids, eye area, eyelashes and other surfaces). Blot your eye to remove excess eye drops. Close the bottle after each use of the eye drops. Use during pregnancy and lactation Pregnancy Data on the use of hypromellose in the form of ophthalmic drugs in pregnant women are absent or limited. The systemic effect of hypromellose after local administration into the conjunctival sac is insignificant, the drug is pharmacologically inert. Lactation There are no data on the penetration of hypromellose and its metabolites into breast milk during topical use of the drug by women who are breastfeeding. Effects on breastfed children are not expected, since the systemic exposure of hypromellose is negligible, in addition, hypromellose is pharmacologically inert. Pregnant or breastfeeding women are advised to consult their doctor before using Slezin. Influence on the ability to drive vehicles and control mechanisms After the use of the drug, temporary visual disturbances are possible, which may adversely affect the ability to drive a car or other potentially dangerous mechanisms. You should refrain from driving and other potentially hazardous activities until your vision is restored. Interaction with other drugs There is no information on possible interactions. In the case of simultaneous use of other drugs, you should consult your doctor. When prescribing the drug Slezin with other drugs, it is necessary to observe an interval between instillations of at least 15 minutes. Contraindications Hypersensitivity to any substance that is part of the drug. Composition 1 ml of the drug contains: Active ingredient: hypromellose 5.0 mg. Excipients: disodium phosphate dodecahydrate, sodium dihydrophosphate monohydrate, sodium chloride, sodium edetate dihydrate, benzalkonium chloride, purified water. Overdose Based on the properties of the drug, no toxic effects are expected in case of overdose when applied topically or if the contents of one vial are accidentally swallowed. Special instructions If the symptoms persist during the use of the drug or the condition worsens (headache, eye pain appear or worsen, in case of visual impairment, redness of the conjunctiva, etc.), it is necessary to stop using the drug and consult a doctor. To maintain the sterility of the medicinal product, do not touch the dropper to the eyes or any other surface. The medicinal product contains benzalkonium chloride, which may cause discoloration of soft contact lenses. The drug should not be used by patients who use contact lenses. It is necessary to remove contact lenses before using the drug and put them back on no earlier than 15 minutes later. Application in children There is no sufficient experience in the use of the drug Slezin in children, therefore, the appointment of children is possible only if the expected therapeutic effect exceeds the risk of side effects. Side effects After topical application of the drug, the following adverse reactions are possible (the frequency of adverse reactions is not known (cannot be determined from the available data)): eye disorders: visual disturbances, eye pain, sensation of a foreign body in the eyes, burning sensation or irritation, ocular hyperemia, sensation of gluing of the eyelids. Hypersensitivity reactions (allergic reactions) are possible. Very rarely, cases of corneal calcification have been reported after the use of eye drops containing phosphates in patients with corneal damage. In the event of adverse reactions, including those not listed in this leaflet, stop using the drug and consult a doctor. Storage conditionsStore at a temperature of 15-25°C in the original packaging. Keep out of the reach of children. Buy Slezin eye drops solution 0.5% 10ml №1 Price for Slezin eye drops solution 0.5% 10ml №1